On Queen Street: Pharma group’s new president shifts industry narrative

fralick_LM
Innovative Medicines Canada new president Pamela Fralick joined the pharmaceutical industry group in December 2016 after 15 years in the non-profit health sector.
Samantha Wright Allen | April 19, 2017
This content is available to lobbymonitor.ca subscribers.

Already a subscriber?

Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
Subscribe
Unlimited access to lobbymonitor.ca and our exclusive newsletters. Free trial